利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

1078 条记录 (耗时 0.028 秒)

    DIETARY FIBER COMPOSITIONS
    33.
    发明申请
    DIETARY FIBER COMPOSITIONS 有权

    公开(公告)号：US20210330729A1

    公开(公告)日：2021-10-28

    申请号：US17313964

    申请日：2021-05-06

    申请人： G&S Laboratories, Inc.

    发明人： Robert A. Ganz ,  Mo E. Saremi ,  William Christopfel

    IPC分类号： A61K36/68 ,  A61K31/732 ,  A61K31/7016 ,  A61K31/733 ,  A61K31/716 ,  A61K31/718 ,  A23L33/125 ,  A23L33/22 ,  A23L33/00 ,  A23L2/52

    摘要： The present disclosure relates to compositions comprising dietary fibers. For example, in some embodiments, the composition comprises two or more fibers (e.g., fibers such as wheat dextrin, inulin, pectin, or potato starch) each present in amount of about 2% to about 6% w/w of the composition. The present disclosure also relates to partially hydrolyzed dietary fibers and methods to prepare a partially hydrolyzed dietary. In some embodiments, the composition comprises further comprises an acid and/or a preservative present in an amount of about 0.01% to about 2% w/w of the composition. In some embodiments, the composition further includes a sweetener and/or a flavoring agent. Such compositions are useful in the treatment or improvement of gastrointestinal diseases.

    USE OF LACTULOSE IN THE TREATMENT OF AUTISM
    37.
    发明申请
    USE OF LACTULOSE IN THE TREATMENT OF AUTISM 有权

    公开(公告)号：US20210252031A1

    公开(公告)日：2021-08-19

    申请号：US17306614

    申请日：2021-05-03

    申请人： Curemark, LLC

    发明人： Joan M. Fallon ,  Richard Feltenstein

    IPC分类号： A61K31/7016 ,  A61K31/045 ,  A61K31/7012 ,  A61K31/047

    摘要： A treatment for autism in which an effective amount of lactulose is administered in order to bind excess ammonia in the gastrointestinal tract, the bloodstream, and the nervous system in order to prevent or reverse ammonia poisoning caused by the administration of certain antibiotics. Lactulose molecules in the colon are fermented by certain bacteria. The fermentation process lowers the colonic pH, and ammonia, in the form of ammonium ions, is used by the bacteria for amino acid and protein synthesis. This lowers the serum ammonia levels and reduces neurotoxicity.

    NOVEL DOSAGE FORMS OF LACTULOSE
    38.
    发明申请
    NOVEL DOSAGE FORMS OF LACTULOSE 有权

    公开(公告)号：US20210252030A1

    公开(公告)日：2021-08-19

    申请号：US17251429

    申请日：2018-10-16

    申请人： P. SIVARAJAKUMAR

    发明人： P. SIVARAJAKUMAR

    IPC分类号： A61K31/7016 ,  A61K9/00 ,  A61K47/12 ,  A61K47/26 ,  A61K47/10 ,  A61K47/44 ,  A61K45/06

    摘要： The present invention discloses oral pharmaceutical compositions of Lactulose particularly useful to treat Constipation and hepatic encephalopathy. In particular, the present invention provides consumable, novel gummy delivery systems comprises Lactulose and methods of making the same. The composition comprises Lactulose, gelling agent, sweetener, buffering agents, flavouring agent, colouring agent, anti-tacking agent and preservative. Such gummy compositions for Lactulose may provide improved patient compliance relative to non-gummy compositions. Further the composition comprises Vitamin, nutritional supplements, minerals, antioxidants, soluble and insoluble fibre, herbs, plants, Probiotics, Pre-biotics amino acids, and digestive enzymes.